Walter and Eliza Hall Institute of Medical Research   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Melbourne Australia (1915)

Organization Overview

First Clinical Trial
2006
NCT00453375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Walter and Eliza Hall Institute of Medical Research | Walter and Eliza Hall Institute of Medical Research; Centre de Recerca en Salut Internacional de Barcelona (CRESIB) | Walter & Eliza Hall Institute of Immunology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Celiac Disease (Phase 2)

Communicable Diseases (Phase 4)

Diabetes Mellitus (Phase 1)

Hypoglycemia (Phase 1)

Infections (Phase 4)

Malaria (Phase 4)

Sexually Transmitted Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 20